LB Pharmaceuticals Inc
LBRX
$47.78
$3.517.92%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2,204.32% | 1,205.89% | 954.37% | -- | -80.28% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 751.98% | -- | 437.55% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 2,449.05% | -- | -- |
| Total Current Assets | 2,303.77% | -- | 968.01% | -- | -- |
|
|
|||||
| Total Current Assets | 2,303.77% | -- | 968.01% | -- | -- |
| Net Property, Plant & Equipment | 41.68% | -- | -10.22% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 53.94% | -- | 54.62% | -- | -- |
| Total Assets | 1,779.11% | -- | 833.18% | -- | -- |
|
|
|||||
| Total Accounts Payable | 449.76% | -- | -8.32% | -- | -- |
| Total Accrued Expenses | 656.75% | -- | -13.52% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.62% | -- | 49.90% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 503.28% | -- | -8.23% | -- | -- |
|
|
|||||
| Total Current Liabilities | 503.28% | -- | -8.23% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 44.28% | -- | -11.72% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -26.86% | -- | -46.37% | -- | -- |
| Total Liabilities | 231.13% | -- | -15.94% | -- | -- |
|
|
|||||
| Common Stock & APIC | 4,909.37% | -- | 4,359.20% | -- | -- |
| Retained Earnings | -74.83% | -- | -24.16% | -- | -- |
| Treasury Stock & Other | -- | -- | 51.35% | -- | -- |
| Total Common Equity | 419.96% | 500.50% | 418.66% | -- | -105.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
|
|
|||||
| Total Common Equity | 419.96% | 500.50% | 418.66% | -- | -105.91% |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3,099.95% | 1,821.81% | 1,429.10% | -- | -83.72% |
|
|
|||||